415 related articles for article (PubMed ID: 21875692)
1. Immunomodulation by chemotherapeutic agents against Leishmaniasis.
Saha P; Mukhopadhyay D; Chatterjee M
Int Immunopharmacol; 2011 Nov; 11(11):1668-79. PubMed ID: 21875692
[TBL] [Abstract][Full Text] [Related]
2. Are neutrophils important host cells for Leishmania parasites?
Ritter U; Frischknecht F; van Zandbergen G
Trends Parasitol; 2009 Nov; 25(11):505-10. PubMed ID: 19762280
[TBL] [Abstract][Full Text] [Related]
3. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
Everlien H; Hockertz S
Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
[TBL] [Abstract][Full Text] [Related]
4. Leishmaniasis.
Herwaldt BL
Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis.
Chattopadhyay A; Jafurulla M
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):7-12. PubMed ID: 22100811
[TBL] [Abstract][Full Text] [Related]
6. Drug delivery: lessons to be learnt from Leishmania studies.
Shaw CD; Carter KC
Nanomedicine (Lond); 2014 Jul; 9(10):1531-44. PubMed ID: 25253500
[TBL] [Abstract][Full Text] [Related]
7. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors in potential drug development for Leishmaniasis.
Das P; Alam MN; Paik D; Karmakar K; De T; Chakraborti T
Indian J Biochem Biophys; 2013 Oct; 50(5):363-76. PubMed ID: 24772958
[TBL] [Abstract][Full Text] [Related]
9. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
10. Modes of action of Leishmanicidal antimicrobial peptides.
Marr AK; McGwire BS; McMaster WR
Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
[TBL] [Abstract][Full Text] [Related]
11. Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta).
Porrozzi R; Teva A; Amaral VF; Santos da Costa MV; Grimaldi G
Am J Trop Med Hyg; 2004 Sep; 71(3):297-305. PubMed ID: 15381810
[TBL] [Abstract][Full Text] [Related]
12. Permissive and protective roles for neutrophils in leishmaniasis.
Carlsen ED; Liang Y; Shelite TR; Walker DH; Melby PC; Soong L
Clin Exp Immunol; 2015 Nov; 182(2):109-18. PubMed ID: 26126690
[TBL] [Abstract][Full Text] [Related]
13. The role of heparan sulfate in host macrophage infection by
Maciej-Hulme ML; Skidmore MA; Price HP
Biochem Soc Trans; 2018 Aug; 46(4):789-796. PubMed ID: 29934302
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of immune cross-talk in leishmaniasis.
Hartley MA; Kohl K; Ronet C; Fasel N
Clin Microbiol Infect; 2013 Feb; 19(2):119-30. PubMed ID: 23398405
[TBL] [Abstract][Full Text] [Related]
15. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
[TBL] [Abstract][Full Text] [Related]
16. Rational approaches for drug designing against leishmaniasis.
Shukla AK; Singh BK; Patra S; Dubey VK
Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
[TBL] [Abstract][Full Text] [Related]
17. Current treatment for cutaneous leishmaniasis: a review.
Palumbo E
Am J Ther; 2009; 16(2):178-82. PubMed ID: 19300044
[TBL] [Abstract][Full Text] [Related]
18. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.
Kram D; Thäle C; Kolodziej H; Kiderlen AF
J Immunol Methods; 2008 Apr; 333(1-2):79-88. PubMed ID: 18313691
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils and Visceral Leishmaniasis: Impact on innate immune response and cross-talks with macrophages and dendritic cells.
Kupani M; Pandey RK; Mehrotra S
J Cell Physiol; 2021 Apr; 236(4):2255-2267. PubMed ID: 33345353
[TBL] [Abstract][Full Text] [Related]
20. Leishmaniasis.
Evans TG
Infect Dis Clin North Am; 1993 Sep; 7(3):527-46. PubMed ID: 8254158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
